Top Medical News
2 hours ago
Sleep disorders commonly occur in patients with ankylosing spondylitis (AS), particularly those with high disease activity, a study has found. Furthermore, treatment with antitumour necrosis factor (anti-TNF)-α improves sleep quality but not polysomnography parameters.
Pearl Toh, 13 hours ago
Targeting mast cells with imatinib, which inhibits the receptor tyrosine kinase KIT, may decrease airway hyperresponsiveness and improve symptoms in patients with severe, poorly controlled asthma, according to a proof-of-principle clinical trial.
14 hours ago
The risk of respiratory syncytial virus hospitalization (RSVH) and respiratory-related illness hospitalization (RIH) does not significantly differ between the first and second year of life in paediatric patients with haemodynamically significant congenital heart disease (HSCHD), a new study shows.
Roshini Claire Anthony, 18 hours ago

An increase in body mass index (BMI) is independently associated with an elevated risk of developing end-stage renal disease (ESRD), according to a Singapore study.

Jairia Dela Cruz, 22 hours ago
A combination of aerobic and resistance exercise training during weight loss yields the greatest improvement in physical function and reduction of frailty, with relative preservation of lean mass, in older adults with obesity as compared with participation in either exercise training programme alone, according to a study.
23 hours ago
Both 2 and 4 percent topical diazepam creams result in substantial improvements in pain and bleeding in chronic anal fissures, a new study shows.
Jackey Suen, Yesterday

The fully-human immunocytokine dekavil (also known as F8-IL10) has demonstrated signs of safety and efficacy in patients with active rheumatoid arthritis (RA) in a phase I study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017.

Special Reports
22 Jun 2017
The University of Science, Malaysia (USM) team, led by Professor Dr Lee Yeong Yeh was recognized for its outstanding research submission that links poor hygiene practices in flood-affected areas to the increased risk in communicable intestinal infections in parts of Malaysia.
22 Jun 2017
Recently in the news, there were reports of outbreaks of avian flu and influenza-like illness (ILI) in Kelantan and Perak, respectively. To help readers gain a better understanding of influenza, MIMS Doctor sat down with Associate Professor Dr Pang Yong Kek to understand how common is influenza in Malaysia and preventive strategies against it.
15 Jun 2017
At a recent morning tea symposium held in conjunction with the Malaysian Urological Conference 2016, Dr Marie Carmela Lapitan discussed about the benefits of combination therapy with alpha-blockers and 5-alpha-reductase inhibitors (5-ARIs) for the management of benign prostatic hyperplasia (BPH).
13 Jun 2017
In an exclusive interview with MIMS Doctor, Dr Yong Junina Fadzil, a consultant paediatrician and paediatric cardiologist at Klinik Pakar Kanak-Kanak Junina shared her perspectives on the roles of balanced nutrition and parental influence in child development.
13 Jun 2017
The common cold is one of the most widespread illness and is a leading cause of visits to the doctor and absenteeism from school and work. While many may see it as merely a harmless inconvenience, the significant repercussions it brings, especially among children cannot be denied. MIMS JPOG recently spoke to Associate Professor Datin Dr Asmiati Abd Hamid to gain her perspectives on the role of zinc and vitamin C in treating paediatric common cold to reduce morbidity and economic losses attributed to the condition.
30 May 2017
Pain is a multidimensional experience that often requires a combination of various approaches to bring about optimal outcomes. At a recent scientific symposium held during the 7th Association of South-East Asian Pain Societies Congress held in Yangon, Myanmar, Professor Stefano Coaccioli discussed the evolution of ns-NSAIDs and how dexketoprofen trometamol (Ketesse®; A. Menarini) can improve acute pain management.
25 May 2017
At a recent lunch symposium during the 14th Annual Scientific Meeting of the Malaysian Society of Hypertension, Dr Chow Yok Wai spoke on the importance of patient adherence in the management of hypertension, highlighting the role of combination therapy in improving treatment outcomes.
Conference Reports
Jackey Suen, 23 Jun 2017

The fully-human immunocytokine dekavil (also known as F8-IL10) has demonstrated signs of safety and efficacy in patients with active rheumatoid arthritis (RA) in a phase I study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017.

Dr. Joseph Delano Fule Robles, 23 Jun 2017

Vobarilizumab, a nanobody consisting of an anti-interleukin 6 (IL-6) receptor domain developed for the treatment of rheumatoid arthritis (RA), is shown to be safe and efficacious in RA patients with inadequate response to methotrexate in a study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held recently in Madrid, Spain.

Audrey Abella, 22 Jun 2017
A single dose of the human glucagon receptor (GCGR) antibody, REMD-477, reduces the amount of insulin necessary and significantly improves glycaemic control in individuals with type 1 diabetes (T1D), according to a study presented at the ADA 2017 in San Diego, California, US.
Elaine Soliven, 22 Jun 2017
Severe obesity in children and adolescents may increase the risk of developing youth-onset diabetes, according to a study presented at the American Diabetes Association’s 77th Scientific Sessions held in San Diego, California, US.
Elaine Tan, 22 Jun 2017

Women who are overweight or obese, as defined by a high body mass index (BMI), abdominal obesity and a higher body fat percentage, have a higher risk of developing rheumatoid arthritis (RA), results of a Danish population cohort study has shown.

Dr. Joseph Delano Fule Robles, 22 Jun 2017

Ixekizumab, a high-affinity monoclonal antibody targeting interleukin-17A (IL-17A), has demonstrated safety and efficacy in patients with psoriatic arthritis resistant to tumour necrosis factor (TNF) inhibitor therapy in a study presented at the European League Against Rheumatism (EULAR) Annual Congress 2017 held recently in Madrid, Spain.

Roshini Claire Anthony, 21 Jun 2017

Insulin degludec had comparable cardiovascular safety and reduced the risk of severe hypoglycaemia compared with insulin glargine U100 in patients with type 2 diabetes and high cardiovascular risk, according to results of the DEVOTE* study.

CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD